GeneDx Holdings Corp.
WGS
$86.48
$0.610.71%
NASDAQ
| 06/30/2026 | 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | |
|---|---|---|---|---|---|
| Net Income | -7,664.51% | -101.70% | 59.80% | 102.49% | 101.20% |
| Total Depreciation and Amortization | 15.68% | 18.49% | 15.54% | 44.76% | 20.52% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 411.18% | 194.61% | 65.83% | -9.84% | -59.34% |
| Change in Net Operating Assets | -82.65% | -207.13% | 36.97% | 6.82% | 22.71% |
| Cash from Operations | -474.02% | -389.79% | 216.78% | 160.15% | 114.16% |
| Capital Expenditure | -122.13% | -73.04% | -246.33% | -267.86% | -184.71% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | 101.02% | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -37.65% | 41.22% | 60.86% | 99.84% | 82.70% |
| Cash from Investing | 28.48% | -71.77% | -104.16% | -47.82% | -0.34% |
| Total Debt Issued | -- | 498.13% | -- | -100.00% | -100.00% |
| Total Debt Repaid | -1,433.61% | -1,579.18% | -13.55% | -42.57% | -18.81% |
| Issuance of Common Stock | -39.44% | 7.04% | 9.07% | 306.35% | 34,930.00% |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | 24.56% | 25.00% | 8.75% | -7.28% | 30.18% |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -176.47% | -136.04% | 236.78% | 229.49% | 117.96% |